Satsuma Pharmaceuticals, Inc.

CIK 1692830 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Satsuma Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Jun 20, 202315-12G0001193125-23-169963
Jun 13, 2023SC 13G/A0001567619-23-006340
Jun 12, 2023SC 13D/A0001104659-23-070413
Jun 12, 202340001104659-23-070513
Jun 8, 202340000899243-23-014864
Jun 8, 2023POS AM0001193125-23-163096
Jun 8, 2023S-8 POS0001193125-23-163105
Jun 8, 20238-K0001193125-23-163082
Jun 8, 202340000899243-23-014901
Jun 8, 202340000899243-23-014894
Jun 8, 202340000899243-23-014885
Jun 8, 2023POS AM0001193125-23-163092
Jun 8, 202340000899243-23-014878
Jun 8, 202340000899243-23-014866
Jun 8, 2023S-8 POS0001193125-23-163106
Jun 8, 202340000899243-23-014876
Jun 8, 2023S-8 POS0001193125-23-163098
Jun 8, 202340000899243-23-014896
Jun 8, 2023SC 14D9/A0001193125-23-163081
Jun 8, 2023SC 13D/A0001193125-23-163095
Jun 8, 2023S-8 POS0001193125-23-163104
Jun 8, 2023POS AM0001193125-23-163090
Jun 8, 2023EFFECT9999999995-23-001674
Jun 8, 2023EFFECT9999999995-23-001673
Jun 8, 2023SC 13E3/A0001193125-23-163080